187 related articles for article (PubMed ID: 15955371)
1. Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies.
Giorgino F; Laviola L; Leonardini A
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S22-9. PubMed ID: 15955371
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
3. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes mellitus: what is the optimal treatment regimen?
Bell DS
Am J Med; 2004 Mar; 116 Suppl 5A():23S-29S. PubMed ID: 15019860
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.
Rosak C
J Diabetes Complications; 2002; 16(1):123-32. PubMed ID: 11872380
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.
Porte D
Diabetes Metab Res Rev; 2001; 17(3):181-8. PubMed ID: 11424231
[TBL] [Abstract][Full Text] [Related]
7. [Role of insulin secretagogues in the treatment of type 2 diabetes].
Radermecker RP
Rev Med Liege; 2005; 60(5-6):402-8. PubMed ID: 16035301
[TBL] [Abstract][Full Text] [Related]
8. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Baretić M; Troskot R
Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
[TBL] [Abstract][Full Text] [Related]
9. [Repaglinide in combination therapy in type 2 diabetes].
Moses R
Diabetes Metab; 1999 Dec; 25 Suppl 7():26-7. PubMed ID: 10746009
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
Ishida H; Kato S; Nishimura M; Mizuno N; Fujimoto S; Mukai E; Kajikawa M; Yamada Y; Odaka H; Ikeda H; Seino Y
Horm Metab Res; 1998 Nov; 30(11):673-8. PubMed ID: 9918384
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
12. Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.
Raptis SA; Dimitriadis GD
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S265-87. PubMed ID: 11460577
[TBL] [Abstract][Full Text] [Related]
13. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
14. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers.
Hofmann CA; Colca JR
Diabetes Care; 1992 Aug; 15(8):1075-8. PubMed ID: 1505314
[No Abstract] [Full Text] [Related]
15. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz HE
Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
[TBL] [Abstract][Full Text] [Related]
16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
17. [Glitazones clinical data: an update].
Guerci B
Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S45-58. PubMed ID: 15959404
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
[TBL] [Abstract][Full Text] [Related]
19. Rationale for and role of thiazolidinediones in type 2 diabetes mellitus.
Lebovitz HE
Am J Cardiol; 2002 Sep; 90(5A):34G-41G. PubMed ID: 12231077
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights.
Mauvais-Jarvis F; Andreelli F; Hanaire-Broutin H; Charbonnel B; Girard J
Diabetes Metab; 2001 Sep; 27(4 Pt 1):415-23. PubMed ID: 11547215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
